Effect of Folic Acid, Vitamin B6 and Vitamin B12 in Diabetic Retinopathy
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government.
Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01921192
Recruitment Status : Unknown
Verified August 2013 by Mariano Malaguarnera, University of Catania. Recruitment status was: Recruiting
Homocysteine, a well-known inducer of vascular endothelial cell damage has been associated with extracellular matrix changes. Many studies demonstrated that high levels of this aminoacid in diabetic patients increases significantly the risk of the development of this pathology. This study has been undertaken to investigate the role of homocysteine and its cofactors (folic acid, vitamin B6 and B12) during the progression of the diabetic retinopathy.
Condition or disease
Non Proliferative Diabetic RetinopathyProliferative Diabetic Retinopathy
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Layout table for eligibility information
Ages Eligible for Study:
40 Years to 65 Years (Adult, Older Adult)
Sexes Eligible for Study:
Accepts Healthy Volunteers:
diabetic patients with proliferative and non proliferative retinopathy
Patients with chronic liver disease Patients with kidney disease.